IMRX 8-K: Board change
Filed with the SEC on · accession 0001790340-26-000099
IMRX filed a 8-K (current report) with the SEC on Nov 9, 2026. Immuneering Corporation appointed Grant C.
Summary of the filing
Immuneering Corporation appointed Grant C. Bogle, MBA, to its Board of Directors as a Class III Director effective November 9, 2026. He will receive standard non-employee director compensation and has entered into the company's standard indemnification agreement.
Key details
✦ Ask GOAX AI about this filing — what it means for IMRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMRX?
Click hereFrequently asked questions
What did IMRX file with the SEC on Nov 9, 2026?
IMRX filed a 8-K (Board change). Immuneering Corporation appointed Grant C. Bogle, MBA, to its Board of Directors as a Class III Director effective November 9, 2026. He will receive standard non-employee director compensation and has entered into the company's standard indemnification agreement.
What does a board change mean for IMRX stock?
Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other IMRX SEC filings
Get alerts when IMRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days